Oncology
Video - Age and Frailty Analyses of Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma in the Phase 3 MAIA and CEPHEUS Trials of Daratumumab + Lenalidomide-Dexamethasone and Bortezomib + Lenalidomide-Dexamethasone
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.